Back to FAIRFAX FINANCIAL HOLDINGS LTD/ CAN FAIRFAX FINANCIAL HOLDINGS LTD/ CAN

XERSXERS
14 quarters

Position history for FAIRFAX FINANCIAL HOLDINGS LTD/ CANFAIRFAX FINANCIAL HOLDINGS LTD/ CAN's holdings in XERIS BIOPHARMA HOLDINGS INC

FAIRFAX FINANCIAL HOLDINGS LTD/ CAN previously held 0 shares of XERS (XERIS BIOPHARMA HOLDINGS INC), worth $0 as of 2025-Q1.

Final Value

$0

Final Shares

0

Total Value Change

-$441,000

Total Shares Change

-151,395

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q1
Latest
Exited
0
-100.0%
$00.0%$5.58
0
2024-Q4
Decreased
139,687
-18.3%
$472,1420.0%$3.38
0
2024-Q3
Unchanged
170,937
0.0%
$485,4610.0%$2.87
0
2024-Q2
Increased
170,937
+12.9%
$382,8990.0%$2.25
28
2024-Q1
Unchanged
151,395
0.0%
$333,0690.0%$2.21
0
2023-Q4
Unchanged
151,395
0.0%
$355,7780.0%$2.35
0
2023-Q3
Unchanged
151,395
0.0%
$281,5950.0%$1.86
0
2023-Q2
Unchanged
151,395
0.0%
$395,1410.0%$2.35
0
2023-Q1
Unchanged
151,395
0.0%
$245,2600.0%$1.46
0
2022-Q4
Unchanged
151,395
0.0%
$199,8410.0%$1.33
0
2022-Q3
Unchanged
151,395
0.0%
$236,0000.0%$1.59
0
2022-Q2
Unchanged
151,395
0.0%
$232,0000.0%$1.48
0
2022-Q1
Unchanged
151,395
0.0%
$388,0000.0%$2.63
0
2021-Q4
New
151,395
-
$441,0000.0%$2.43
33

Other major holders of XERS: BlackRock, Inc., VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used